Cardiac sympathetic innervation and cardiac resynchronization therapy

Heart Failure Reviews

Volumn 19, Issue 5, 2014, Pages 567-573

  Scholtens, A M ^a   Braat, A J A T ^a   Tuinenburg, A ^a   Meine, M ^a   Verberne, H J ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Biventricular pacing; Heart failure; MIBG; Resynchronization; Sympathetic innervation

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

CARDIAC RESYNCHRONIZATION THERAPY; DISEASE SEVERITY; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART SCINTISCANNING; HUMAN; ISCHEMIC CARDIOMYOPATHY; NEW YORK HEART ASSOCIATION CLASS; NONISCHEMIC CARDIOMYOPATHY; PROGNOSIS; REVIEW; SYMPATHETIC INNERVATION; ADRENERGIC SYSTEM; HEART; INNERVATION; PROCEDURES; SCINTISCANNING;

CARDIAC RESYNCHRONIZATION THERAPY; HEART; HEART FAILURE; HUMANS; RADIONUCLIDE IMAGING; SYMPATHETIC NERVOUS SYSTEM;

EID: 84906934455     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-013-9400-0     Document Type: Review

References (23)

1. Authors/Task Force Members, Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C et al (2010) 2010 Focused update of ESC guidelines on device therapy in heart failure: an update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the heart failure association and the European heart rhythm association. Eur Heart J 31:2677-2687
2. Pires LA, Abraham WT, Young JB, Johnson KM (2006) Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the multicenter InSync randomized clinical evaluation (MIRACLE) and multicenter InSync ICD randomized clinical evaluation (MIRACLE-ICD) trials. Am Heart J 151:837-843
3. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA et al (2010) Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure) study. J Am Coll Cardiol 55:2212-2221
4. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H et al (2007) Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European society of cardiology. Developed in collaboration with the European heart rhythm association. Eur Heart J 28:2256-2295 (Pubitemid 47428944)
5. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA et al (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European society of cardiology. Developed in collaboration with the heart failure association of the ESC (HFA) and endorsed by the European society of intensive care medicine (ESICM). Eur J Heart Fail 10:933-989
6. Erol-Yilmaz A, Verberne HJ, Schrama TA, Hrudova J, De Winter RJ, Van Eck-Smit BL et al (2005) Cardiac resynchronization induces favorable neurohumoral changes. Pacing Clin Electrophysiol 28:304-310 (Pubitemid 40613059)
7. Higuchi K, Toyama T, Tada H, Naito S, Ohshima S, Kurabayashi M (2006) Usefulness of biventricular pacing to improve cardiac symptoms, exercise capacity and sympathetic nerve activity in patients with moderate to severe chronic heart failure. Circ J 70:703-709 (Pubitemid 43797781)
8. Gould PA, Kong G, Kalff V, Duffy SJ, Taylor AJ, Kelly MJ et al (2007) Improvement in cardiac adrenergic function post biventricular pacing for heart failure. Europace 9:751-756 (Pubitemid 47371648)
9. Nishioka SA, Martinelli Filho M, Brandao SC, Giorgi MC, Vieira ML, Costa R et al (2007) Cardiac sympathetic activity pre and post resynchronization therapy evaluated by 123I-MIBG myocardial scintigraphy. J Nucl Cardiol 14:852-859 (Pubitemid 350082581)
10. Burri H, Sunthorn H, Somsen A, Fleury E, Stettler C, Shah D et al (2008) Improvement in cardiac sympathetic nerve activity in responders to resynchronization therapy. Europace 10:374-378 (Pubitemid 351773736)
11. Cha YM, Oh J, Miyazaki C, Hayes DL, Rea RF, Shen WK et al (2008) Cardiac resynchronization therapy upregulates cardiac autonomic control. J Cardiovasc Electrophysiol 19:1045-1052
12. Cha YM, Chareonthaitawee P, Dong YX, Kemp BJ, Oh JK, Miyazaki C et al (2011) Cardiac sympathetic reserve and response to cardiac resynchronization therapy. Circ Heart Fail 4:339-344
13. Shinohara T, Takahashi N, Saito S, Okada N, Wakisaka O, Yufu K et al (2011) Effect of cardiac resynchronization therapy on cardiac sympathetic nervous dysfunction and serum C-reactive protein level. Pacing Clin Electrophysiol 34:1225-1230
14. Tanaka H, Tatsumi K, Fujiwara S, Tsuji T, Kaneko A, Ryo K et al (2012) Effect of left ventricular dyssynchrony on cardiac sympathetic activity in heart failure patients with wide QRS duration. Circ J 76:382-389
15. Xu YZ, Cha YM, Feng D, Powell BD, Wiste HJ, Hua W et al (2012) Impact of myocardial scarring on outcomes of cardiac resynchronization therapy: extent or location? J Nucl Med 53:47-54
16. Adelstein EC, Tanaka H, Soman P, Miske G, Haberman SC, Saba SF et al (2011) Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy. Eur Heart J 32:93-103
17. D'Andrea A, Caso P, Scarafile R, Riegler L, Salerno G, Castaldo F et al (2009) Effects of global longitudinal strain and total scar burden on response to cardiac resynchronization therapy in patients with ischaemic dilated cardiomyopathy. Eur J Heart Fail 11:58-67
18. Kandala J, Altman R, Park M, Singh J (2012) Clinical, laboratory, and pacing predictors of CRT response. J Cardiovasc Transl Res 5:196-212. doi:10.1007/s12265-012-9352-0
19. Bleeker GB, Bax JJ, Fung JW, van der Wall EE, Zhang Q, Schalij MJ et al (2006) Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Am J Cardiol 97:260-263 (Pubitemid 43139248)
20. 123I- metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM cardiovascular committee and the European council of nuclear cardiology. Eur J Nucl Med Mol Imaging 37:1802-1812
21. Dobbeleir AA, Hambye AS, Franken PR (1999) Influence of high-energy photons on the spectrum of iodine-123 with low- and medium-energy collimators: consequences for imaging with 123I-labelled compounds in clinical practice. Eur J Nucl Med 26:655-658 (Pubitemid 29263637)
22. Inoue Y, Suzuki A, Shirouzu I, Machida T, Yoshizawa Y, Akita F et al (2003) Effect of collimator choice on quantitative assessment of cardiac iodine 123 MIBG uptake. J Nucl Cardiol 10:623-632 (Pubitemid 38035397)
23. 123I-MIBG heart/mediastinum ratios: a phantomstudy.Eur JNucl Med Mol Imaging 32:1100-1710